Ningxi Yu

478 total citations
14 papers, 375 citations indexed

About

Ningxi Yu is a scholar working on Molecular Biology, Pharmacology and Computational Theory and Mathematics. According to data from OpenAlex, Ningxi Yu has authored 14 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Pharmacology and 3 papers in Computational Theory and Mathematics. Recurrent topics in Ningxi Yu's work include RNA modifications and cancer (6 papers), RNA and protein synthesis mechanisms (6 papers) and Computational Drug Discovery Methods (3 papers). Ningxi Yu is often cited by papers focused on RNA modifications and cancer (6 papers), RNA and protein synthesis mechanisms (6 papers) and Computational Drug Discovery Methods (3 papers). Ningxi Yu collaborates with scholars based in China, United States and Germany. Ningxi Yu's co-authors include Patrick A. Limbach, Xiaoyu Cao, Robert Ross, Guang‐Fu Yang, Manasses Jora, Xiao‐Lei Zhu, Wen‐Chao Yang, Balasubrahmanyam Addepalli, Ge‐Fei Hao and Serenus Hua and has published in prestigious journals such as Analytical Chemistry, Journal of Bacteriology and Analytica Chimica Acta.

In The Last Decade

Ningxi Yu

14 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ningxi Yu China	11	304	51	44	36	34	14	375
Karl J. Okolotowicz United States	13	164 0.5×	24 0.5×	46 1.0×	19 0.5×	102 3.0×	20	337
Jennifer B. Munzner United States	5	100 0.3×	62 1.2×	58 1.3×	92 2.6×	11 0.3×	5	282
Evelyne Muller France	8	248 0.8×	43 0.8×	19 0.4×	10 0.3×	58 1.7×	10	349
Yashraj Kulkarni United States	8	228 0.8×	21 0.4×	20 0.5×	15 0.4×	10 0.3×	10	321
Lailiang Qu China	16	281 0.9×	34 0.7×	66 1.5×	35 1.0×	119 3.5×	26	507
Rebecca L. Frkic Australia	9	227 0.7×	14 0.3×	27 0.6×	34 0.9×	69 2.0×	23	331
Mónika Bálint Hungary	12	238 0.8×	24 0.5×	42 1.0×	68 1.9×	37 1.1×	23	363
Núria Villegas Spain	10	205 0.7×	14 0.3×	18 0.4×	45 1.3×	8 0.2×	17	316
Jinxin Xu China	13	258 0.8×	21 0.4×	42 1.0×	16 0.4×	30 0.9×	27	399

Countries citing papers authored by Ningxi Yu

Since Specialization

Citations

This map shows the geographic impact of Ningxi Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ningxi Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ningxi Yu more than expected).

Fields of papers citing papers by Ningxi Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ningxi Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ningxi Yu. The network helps show where Ningxi Yu may publish in the future.

Co-authorship network of co-authors of Ningxi Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Ningxi Yu. A scholar is included among the top collaborators of Ningxi Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ningxi Yu. Ningxi Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Hu, Weiqing, Li Zou, Ningxi Yu, et al.. (2023). Catalpol rescues LPS-induced cognitive impairment via inhibition of NF-Κb-regulated neuroinflammation and up-regulation of TrkB-mediated BDNF secretion in mice. Journal of Ethnopharmacology. 319(Pt 3). 117345–117345. 11 indexed citations

Sun, Si, Yitong Xu, Ningxi Yu, et al.. (2023). Catalpol Alleviates Ischemic Stroke Through Promoting Angiogenesis and Facilitating Proliferation and Differentiation of Neural Stem Cells via the VEGF-A/KDR Pathway. Molecular Neurobiology. 60(11). 6227–6247. 12 indexed citations

Ross, Robert, Ningxi Yu, Ruoxia Zhao, Andrew Wood, & Patrick A. Limbach. (2023). Automated Identification of Modified Nucleosides during HRAM-LC-MS/MS using a Metabolomics ID Workflow with Neutral Loss Detection. Journal of the American Society for Mass Spectrometry. 34(12). 2785–2792. 5 indexed citations

Yu, Ningxi, Manasses Jora, Carlos G. Acevedo‐Rocha, et al.. (2019). tRNA Modification Profiles and Codon-Decoding Strategies in Methanocaldococcus jannaschii. Journal of Bacteriology. 201(9). 40 indexed citations

Jiang, Tao, Ningxi Yu, Jaeah Kim, et al.. (2019). Oligonucleotide Sequence Mapping of Large Therapeutic mRNAs via Parallel Ribonuclease Digestions and LC-MS/MS. Analytical Chemistry. 91(13). 8500–8506. 51 indexed citations

Yu, Ningxi, et al.. (2018). Improving RNA modification mapping sequence coverage by LC-MS through a nonspecific RNase U2-E49A mutant. Analytica Chimica Acta. 1036. 73–79. 17 indexed citations

Yu, Ningxi, et al.. (2018). Improved application of RNAModMapper – An RNA modification mapping software tool – For analysis of liquid chromatography tandem mass spectrometry (LC-MS/MS) data. Methods. 156. 128–138. 26 indexed citations

Yu, Ningxi, et al.. (2017). RNAModMapper: RNA Modification Mapping Software for Analysis of Liquid Chromatography Tandem Mass Spectrometry Data. Analytical Chemistry. 89(20). 10744–10752. 53 indexed citations

Ross, Robert, Xiaoyu Cao, Ningxi Yu, & Patrick A. Limbach. (2016). Sequence mapping of transfer RNA chemical modifications by liquid chromatography tandem mass spectrometry. Methods. 107. 73–78. 74 indexed citations

10.

Zhu, Xiao‐Lei, Ningxi Yu, Ge‐Fei Hao, Wen‐Chao Yang, & Guang‐Fu Yang. (2013). Structural basis of femtomolar inhibitors for acetylcholinesterase subtype selectivity: Insights from computational simulations. Journal of Molecular Graphics and Modelling. 41. 55–60. 7 indexed citations

11.

Peng, Da‐Yong, Qi Sun, Xiao‐Lei Zhu, et al.. (2012). Design, synthesis, and bioevaluation of benzamides: Novel acetylcholinesterase inhibitors with multi-functions on butylcholinesterase, Aβ aggregation, and β-secretase. Bioorganic & Medicinal Chemistry. 20(22). 6739–6750. 39 indexed citations

12.

Yang, Wen‐Chao, Qi Sun, Ningxi Yu, Xiao‐Lei Zhu, & Guang‐Fu Yang. (2012). [Design of acetylcholinesterase inhibitor for Alzheimer's disease therapy: from multi-binding site inhibitors to multi-target directed ligands].. PubMed. 47(3). 313–21. 1 indexed citations

13.

Hao, Ge‐Fei, Ying Tan, Ningxi Yu, & Guang‐Fu Yang. (2011). Structure–activity relationships of diphenyl-ether as protoporphyrinogen oxidase inhibitors: insights from computational simulations. Journal of Computer-Aided Molecular Design. 25(3). 213–222. 23 indexed citations

14.

Zhu, Xiao‐Lei, Wen‐Chao Yang, Ningxi Yu, Sheng‐Gang Yang, & Guang‐Fu Yang. (2010). Computational simulations of structural role of the active-site W374C mutation of acetyl-coenzyme-A carboxylase: Multi-drug resistance mechanism. Journal of Molecular Modeling. 17(3). 495–503. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact